Amarin Corporation plc - Depositary Receipt (Common Stock)
US ˙ NasdaqCM ˙ US0231112063

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for David M Stack. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at David M Stack har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:PCRX / Pacira BioSciences, Inc. CEO and Chairman, Director 186.481
Director 0
US:AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Director 36.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af David M Stack. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-06-04 AMRN STACK DAVID M 10.000 4,5350 500 90,7000 45.350 82 5.84 -42.430 -93,56
2021-06-03 AMRN STACK DAVID M 5.000 4,6230 250 92,4600 23.115
2020-11-30 AMRN STACK DAVID M 25.000 4,8607 1.250 97,2140 121.518

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Insider Trades
Insidersalg AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Insider Trades
Insiderkøb PCRX / Pacira BioSciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PCRX / Pacira BioSciences, Inc. Insider Trades
Insidersalg PCRX / Pacira BioSciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-06-07 PCRX STACK DAVID M 5.326 37,8650 5.326 37,8650 201.669 323 25.5000 -65.855 -32,66
2023-06-06 PCRX STACK DAVID M 5.058 38,9910 5.058 38,9910 197.216
2022-06-06 PCRX STACK DAVID M 11.965 61,3740 11.965 61,3740 734.340
2021-06-04 PCRX STACK DAVID M 14.905 61,0370 14.905 61,0370 909.756
2020-06-08 PCRX STACK DAVID M 15.390 48,0800 15.390 48,0800 739.951
2020-06-08 PCRX STACK DAVID M 1.721 48,4900 1.721 48,4900 83.451
2020-06-04 PCRX STACK DAVID M 14.314 46,3310 14.314 46,3310 663.182
2019-06-04 PCRX STACK DAVID M 12.385 42,9100 12.385 42,9100 531.440
2018-06-06 PCRX STACK DAVID M 8.615 35,6100 8.615 35,6100 306.780
2017-11-15 PCRX STACK DAVID M 56.985 38,3200 56.985 38,3200 2.183.665
2017-11-15 PCRX STACK DAVID M 1.900 38,9700 1.900 38,9700 74.043
2017-06-05 PCRX STACK DAVID M 4.311 43,3210 4.311 43,3210 186.757

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PCRX / Pacira BioSciences, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af David M Stack som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-06-16 2023-06-14 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 32.700 186.481 21,26
2023-06-07 2023-06-07 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -5.326 153.781 -3,35 37,86 -201.669 5.822.918
2023-06-07 2023-06-06 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -5.058 159.107 -3,08 38,99 -197.216 6.203.741
2022-06-08 2022-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 21.500 163.751 15,11
2022-06-08 2022-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -501 142.251 -0,35 61,96 -31.042 8.813.872
2022-06-08 2022-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -1.282 142.752 -0,89 61,31 -78.599 8.752.125
2022-06-08 2022-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -5.006 144.034 -3,36 60,33 -302.012 8.689.571
2022-06-08 2022-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -7.039 149.040 -4,51 59,10 -416.005 8.808.264
2022-06-08 2022-06-06 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -11.965 156.079 -7,12 61,37 -734.340 9.579.193
2022-05-02 2022-04-28 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -22.500 0 -100,00
2022-05-02 2022-04-28 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 22.500 168.044 15,46 10,81 243.225 1.816.556
2022-04-05 2022-03-31 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -22.500 22.500 -50,00
2022-04-05 2022-03-31 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 22.500 145.544 18,29 10,81 243.225 1.573.331
2022-01-27 2022-01-25 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -13.670 45.000 -23,30
2022-01-27 2022-01-25 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 13.670 123.044 12,50 10,81 147.773 1.330.106
2022-01-13 2022-01-11 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 58.670 -20,36
2022-01-13 2022-01-11 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 15.000 109.374 15,89 10,81 162.150 1.182.333
2021-11-18 2021-11-16 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 73.670 -16,92
2021-11-18 2021-11-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 15.000 94.085 18,97 10,81 162.150 1.017.059
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -13.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -13.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -13.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -13.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -10.000 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -72.683 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
D - Sale to Issuer -91.954 0 -100,00
2021-08-05 2021-08-05 4 CHMA CHIASMA, INC
Common Stock
D - Sale to Issuer -25.000 0 -100,00
2021-06-16 2021-06-14 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 36.000 36.000
2021-06-16 2021-06-14 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
A - Award 45.953 45.953
2021-06-11 2021-06-09 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 133.400 133.400
2021-06-11 2021-06-09 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 17.800 78.956 29,11
2021-06-08 2021-06-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -14.905 61.156 -19,60 61,04 -909.756 3.732.779
2021-06-07 2021-06-04 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
P - Purchase 10.000 40.000 33,33 4,54 45.350 181.400
2021-06-07 2021-06-03 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
P - Purchase 5.000 30.000 20,00 4,62 23.115 138.690
2021-05-13 2021-05-12 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -21.250 88.670 -19,33
2021-05-13 2021-05-12 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -3.611 76.061 -4,53 62,41 -225.363 4.746.967
2021-05-13 2021-05-12 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -14.669 79.672 -15,55 62,08 -910.652 4.946.038
2021-05-13 2021-05-12 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -2.970 94.341 -3,05 60,76 -180.457 5.732.159
2021-05-13 2021-05-12 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 21.250 97.311 27,94 10,81 229.712 1.051.932
2021-05-13 2021-05-11 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -21.250 109.920 -16,20
2021-05-13 2021-05-11 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -7.932 76.061 -9,44 61,19 -485.359 4.654.173
2021-05-13 2021-05-11 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -13.318 83.993 -13,69 60,78 -809.468 5.105.095
2021-05-13 2021-05-11 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 21.250 97.311 27,94 10,81 229.712 1.051.932
2021-05-13 2021-03-24 4 PCRX Pacira BioSciences, Inc.
Common Stock
G - Gift -1.080 97.273 -1,10
2021-02-04 2021-02-03 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -21.250 131.170 -13,94
2021-02-04 2021-02-03 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -14.350 76.061 -15,87 71,42 -1.024.877 5.432.277
2021-02-04 2021-02-03 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -6.900 90.411 -7,09 70,78 -488.382 6.399.291
2021-02-04 2021-02-03 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 21.250 97.311 27,94 10,81 229.712 1.051.932
2021-02-04 2021-02-02 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -21.250 152.420 -12,24
2021-02-04 2021-02-02 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -4.100 76.061 -5,11 70,20 -287.820 5.339.482
2021-02-04 2021-02-02 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -14.250 80.161 -15,09 69,38 -988.665 5.561.570
2021-02-04 2021-02-02 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -2.900 94.411 -2,98 68,41 -198.389 6.458.657
2021-02-04 2021-02-02 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 21.250 97.311 27,94 10,81 229.712 1.051.932
2020-12-02 2020-11-30 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
P - Purchase 25.000 25.000 4,86 121.518 121.518
2020-12-01 2020-11-30 4 CHMA CHIASMA, INC
Common Stock
P - Purchase 25.000 25.000 4,27 106.858 106.858
2020-10-16 2020-10-16 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -30.000 173.670 -14,73
2020-10-16 2020-10-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -30.000 173.377 -14,75 55,56 -1.666.800 9.632.826
2020-10-16 2020-10-16 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 30.000 203.377 17,30 10,81 324.300 2.198.505
2020-10-16 2020-10-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -30.000 203.670 -12,84
2020-10-16 2020-10-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -30.000 173.377 -14,75 55,00 -1.650.000 9.535.735
2020-10-16 2020-10-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 30.000 203.377 17,30 10,81 324.300 2.198.505
2020-10-16 2020-10-14 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -30.000 233.670 -11,38
2020-10-16 2020-10-14 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -30.000 173.377 -14,75 55,53 -1.665.900 9.627.625
2020-10-16 2020-10-14 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 30.000 203.377 17,30 10,81 324.300 2.198.505
2020-08-19 2020-08-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -3.217 173.377 -1,82 62,34 -200.548 10.808.322
2020-08-19 2020-08-17 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -11.783 176.594 -6,26 61,79 -728.072 10.911.743
2020-07-17 2020-07-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -12.000 188.377 -5,99 56,88 -682.560 10.714.884
2020-07-15 2020-07-13 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 27.191 27.191
2020-07-15 2020-07-13 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
A - Award 34.805 34.805
2020-06-12 2020-06-11 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 13.000 13.000
2020-06-11 2020-06-09 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 275.000 275.000
2020-06-11 2020-06-09 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 33.300 200.209 19,95
2020-06-08 2020-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -1.721 166.909 -1,02 48,49 -83.451 8.093.417
2020-06-08 2020-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -15.390 168.630 -8,36 48,08 -739.951 8.107.730
2020-06-08 2020-06-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -14.314 184.020 -7,22 46,33 -663.182 8.525.831
2020-02-25 2020-02-21 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -16.356 0 -100,00
2020-02-25 2020-02-21 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -19.500 0 -100,00
2020-02-25 2020-02-21 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 16.356 198.334 8,99 5,49 89.794 1.088.854
2020-02-25 2020-02-21 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 19.500 181.978 12,00 1,61 31.395 292.985
2020-01-17 2020-01-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -25.000 243.129 -9,32
2020-01-17 2020-01-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -1.975 1.208 -62,05 43,48 -85.873 52.524
2020-01-17 2020-01-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -23.025 3.183 -87,85 42,61 -981.095 135.628
2020-01-17 2020-01-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 25.000 26.208 2.069,54 10,81 270.250 283.308
2019-12-30 2019-12-26 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -10.000 16.356 -37,94
2019-12-30 2019-12-26 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -10.000 16.356 -37,94
2019-12-30 2019-12-26 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 10.000 162.299 6,57 5,49 54.900 891.022
2019-12-30 2019-12-26 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 10.000 152.299 7,03 1,61 16.100 245.201
2019-11-19 2019-11-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -25.000 288.670 -7,97
2019-11-19 2019-11-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -25.000 1.208 -95,39 42,81 -1.070.250 51.714
2019-11-19 2019-11-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 25.000 26.208 2.069,54 10,81 270.250 283.308
2019-11-19 2019-11-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -45.000 142.299 -24,03 42,81 -1.926.450 6.091.820
2019-10-04 2019-10-02 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -10.000 26.356 -27,51
2019-10-04 2019-10-02 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -7.000 29.500 -19,18
2019-10-04 2019-10-02 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 10.000 187.299 5,64 5,49 54.900 1.028.272
2019-10-04 2019-10-02 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 7.000 177.299 4,11 1,61 11.270 285.451
2019-09-20 2019-09-18 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -6.500 36.356 -15,17
2019-09-20 2019-09-18 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -7.500 36.500 -17,05
2019-09-20 2019-09-18 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 6.500 170.299 3,97 5,49 35.685 934.942
2019-09-20 2019-09-18 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 7.500 163.799 4,80 1,61 12.075 263.716
2019-08-16 2019-08-15 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -12.849 0 -100,00
2019-08-16 2019-08-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -2.391 156.299 -1,51 39,61 -94.708 6.191.003
2019-08-16 2019-08-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -10.458 158.690 -6,18 39,05 -408.385 6.196.844
2019-08-16 2019-08-15 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise X 12.849 169.148 8,22 10,81 138.898 1.828.490
2019-07-12 2019-07-11 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -28.847 0 -100,00
2019-07-12 2019-07-11 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -23.144 0 -100,00
2019-07-12 2019-07-11 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -51.991 0 -100,00 22,28 -1.158.354
2019-07-12 2019-07-11 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 28.847 51.991 124,64 2,19 63.175 113.860
2019-07-12 2019-07-11 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 23.144 23.144 2,50 57.860 57.860
2019-07-10 2019-07-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -700 156.299 -0,45 43,42 -30.394 6.786.503
2019-07-10 2019-07-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale X -12.415 156.999 -7,33 42,85 -531.983 6.727.407
2019-06-17 2019-06-13 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 13.000 13.000
2019-06-13 2019-06-11 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -9.000 42.856 -17,36
2019-06-13 2019-06-11 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 44.000 -25,42
2019-06-13 2019-06-11 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 9.000 169.231 5,62 5,49 49.410 929.078
2019-06-13 2019-06-11 4 PCRX Pacira BioSciences, Inc.
Common Stock
M - Exercise 15.000 160.231 10,33 1,61 24.150 257.972
2019-06-06 2019-06-05 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 142.100 142.100
2019-06-06 2019-06-05 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 23.700 145.231 19,50
2019-06-06 2019-06-04 4 PCRX Pacira BioSciences, Inc.
Common Stock
S - Sale -12.385 121.531 -9,25 42,91 -531.440 5.214.895
2019-05-31 2019-05-29 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -33.799 0 -100,00
2019-05-31 2019-05-29 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -33.799 0 -100,00 18,45 -623.534
2019-05-31 2019-05-29 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 33.799 33.799 3,21 108.495 108.495
2019-05-21 2019-05-20 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 7.428 7.428
2019-05-21 2019-05-20 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
A - Award 9.658 9.658
2019-05-21 2019-05-17 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -13.174 33.799 -28,05
2019-05-21 2019-05-17 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -13.174 0 -100,00 18,00 -237.139
2019-05-21 2019-05-17 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 13.174 13.174 3,21 42.289 42.289
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -11.572 0 -100,00
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -28.500 0 -100,00
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -13.500 0 -100,00
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -45.000 0 -100,00
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -21.146 0 -100,00
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -5.786 11.572 -33,33
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -98.572 0 -100,00 18,00 -1.774.296
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 11.572 98.572 13,30 2,50 28.930 246.430
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 28.500 87.000 48,72 1,87 53.295 162.690
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 13.500 58.500 30,00 5,58 75.330 326.430
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 45.000 45.000 9,34 420.300 420.300
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -26.932 0 -100,00 18,00 -484.776
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 21.146 26.932 365,47 3,06 64.707 82.412
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 5.786 5.786 2,50 14.465 14.465
2018-12-20 2018-12-18 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -6.000 51.856 -10,37
2018-12-20 2018-12-18 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -6.000 51.856 -10,37
2018-12-20 2018-12-18 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.000 133.683 4,70 5,49 32.940 733.920
2018-12-20 2018-12-18 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.000 127.683 4,93 1,61 9.660 205.570
2018-11-19 2018-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.558 121.683 -3,61 47,70 -217.417 5.804.279
2018-11-19 2018-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -10.442 126.241 -7,64 47,25 -493.384 5.964.887
2018-10-15 2018-10-11 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 57.856 -20,59
2018-10-15 2018-10-11 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -18.190 65.000 -21,87
2018-10-15 2018-10-11 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -11.810 0 -100,00
2018-10-15 2018-10-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 136.683 12,33 5,49 82.350 750.390
2018-10-15 2018-10-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 18.190 121.683 17,58 1,61 29.286 195.910
2018-10-15 2018-10-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 11.810 103.493 12,88 1,61 19.014 166.624
2018-10-02 2018-05-14 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 31.153 31.153
2018-10-02 2018-05-14 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 46.973 46.973
2018-08-16 2018-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -13.481 0 -100,00
2018-08-16 2018-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -610 0 -100,00
2018-08-16 2018-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -11.864 91.683 -11,46 47,69 -565.794 4.372.362
2018-08-16 2018-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -21.198 103.547 -16,99 47,11 -998.638 4.878.099
2018-08-16 2018-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 13.481 124.745 12,12 10,81 145.730 1.348.493
2018-08-16 2018-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 610 111.264 0,55 5,49 3.349 610.839
2018-06-15 2018-06-13 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 170.250 170.250
2018-06-15 2018-06-13 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 28.375 110.415 34,59
2018-06-11 2018-06-07 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 13.000 13.000
2018-06-08 2018-06-07 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.600 82.040 -3,07 37,53 -97.578 3.078.961
2018-06-08 2018-06-07 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.191 84.640 -7,83 36,63 -263.406 3.100.363
2018-06-08 2018-06-06 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale -8.615 91.831 -8,58 35,61 -306.780 3.270.102
2018-05-17 2018-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -10.000 13.481 -42,59
2018-05-17 2018-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 610 -96,09
2018-05-17 2018-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.894 100.446 -3,73 34,34 -133.720 3.449.316
2018-05-17 2018-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -21.106 104.340 -16,82 33,69 -711.061 3.515.215
2018-05-17 2018-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 10.000 125.446 8,66 10,81 108.100 1.356.071
2018-05-17 2018-05-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 15.000 115.446 14,93 5,49 82.350 633.799
2018-01-12 2018-01-10 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -28.885 83.190 -25,77
2018-01-12 2018-01-10 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -885 100.446 -0,87 41,97 -37.143 4.215.719
2018-01-12 2018-01-10 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.628 101.331 -4,37 41,03 -189.887 4.157.611
2018-01-12 2018-01-10 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -23.372 105.959 -18,07 39,96 -933.945 4.234.122
2018-01-12 2018-01-10 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 28.885 129.331 28,76 1,61 46.505 208.223
2017-11-17 2017-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -28.885 112.075 -20,49
2017-11-17 2017-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale -1.900 100.279 -1,86 38,97 -74.043 3.907.873
2017-11-17 2017-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale -56.985 102.179 -35,80 38,32 -2.183.665 3.915.499
2017-11-17 2017-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 28.885 159.164 22,17 1,61 46.505 256.254
2017-08-17 2017-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -28.885 11.810 -70,98
2017-08-17 2017-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -28.885 130.279 -18,15 36,37 -1.050.547 4.738.247
2017-08-17 2017-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 28.885 159.164 22,17 1,61 46.505 256.254
2017-07-26 2017-07-24 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 140.960 -9,62
2017-07-26 2017-07-24 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 130.279 13,01 1,61 24.150 209.749
2017-06-27 2017-06-23 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 155.960 -8,77
2017-06-27 2017-06-23 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 115.059 14,99 1,61 24.150 185.245
2017-06-19 2017-06-15 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 13.000 13.000
2017-06-16 2017-06-14 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 81.000 81.000
2017-06-16 2017-06-14 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 40.500 100.059 68,00
2017-06-07 2017-06-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale -4.311 59.559 -6,75 43,32 -186.757 2.580.155
2017-05-17 2017-05-15 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 14.706 14.706
2017-05-17 2017-05-15 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 21.146 21.146
2017-01-19 2017-01-17 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 15.610 -49,00
2017-01-19 2017-01-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.300 63.870 -1,99 38,81 -50.453 2.478.795
2017-01-19 2017-01-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -13.700 65.170 -17,37 38,37 -525.669 2.500.573
2017-01-19 2017-01-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 15.000 78.870 23,49 5,49 82.350 432.996
2016-12-09 2016-12-07 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 60.000 60.000
2016-11-17 2016-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 30.610 -32,89
2016-11-17 2016-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.800 63.637 -2,75 37,76 -67.968 2.402.933
2016-11-17 2016-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -13.200 65.437 -16,79 37,21 -491.172 2.434.911
2016-11-17 2016-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 15.000 78.637 23,57 5,49 82.350 431.717
2016-10-07 2016-10-05 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -30.000 40.695 -42,44
2016-10-07 2016-10-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 30.000 63.637 89,19 1,61 48.300 102.456
2016-08-17 2016-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 45.610 -24,75
2016-08-17 2016-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.000 33.637 -30,84 45,32 -679.800 1.524.429
2016-08-17 2016-08-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 15.000 48.637 44,59 5,49 82.350 267.017
2016-07-13 2016-07-11 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 20.548 20.548
2016-07-13 2016-07-11 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 28.847 28.847
2016-06-17 2016-06-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 66.250 66.250
2016-06-17 2016-06-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 33.125 33.410 11.622,81
2016-06-13 2016-06-09 4 CHMA CHIASMA, INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2016-04-19 2016-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -25.000 60.610 -29,20
2016-04-19 2016-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -6.350 285 -95,70 64,62 -410.337 18.417
2016-04-19 2016-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -18.650 6.635 -73,76 63,97 -1.193.040 424.441
2016-04-19 2016-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 25.000 25.285 8.771,93 5,49 137.250 138.815
2016-01-19 2016-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 70.695 -17,50
2016-01-19 2016-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.392 285 -93,91 64,46 -283.108 18.371
2016-01-19 2016-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -9.608 4.677 -67,26 63,69 -611.934 297.878
2016-01-19 2016-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.000 14.285 -6,54 62,55 -62.550 893.527
2016-01-19 2016-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 15.000 15.285 5.263,16 1,61 24.150 24.609
2015-10-19 2015-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 85.695 -14,90
2015-10-19 2015-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -600 176 -77,32 38,49 -23.094 6.774
2015-10-19 2015-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.799 776 -90,95 37,89 -295.504 29.403
2015-10-19 2015-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -6.601 8.575 -43,50 37,11 -244.963 318.218
2015-10-19 2015-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise X 15.000 15.176 8.522,73 1,61 24.150 24.433
2015-07-17 2015-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 100.695 -12,97
2015-07-17 2015-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.000 176 -98,84 67,78 -1.016.700 11.929
2015-07-17 2015-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 15.176 8.522,73 1,61 24.150 24.433
2015-07-08 2015-07-06 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 18.000 18.000
2015-07-08 2015-07-06 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 40.500 40.500
2015-07-08 2015-07-06 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 23.144 23.144
2015-07-08 2015-07-06 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 17.358 17.358
2015-04-17 2015-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -25.000 115.695 -17,77
2015-04-17 2015-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -25.000 59 -99,76 90,50 -2.262.475 5.339
2015-04-17 2015-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 25.000 25.059 42.372,88 1,61 40.250 40.345
2015-01-20 2015-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 140.695 -9,63
2015-01-20 2015-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.600 1.267 -55,81 98,74 -157.984 125.104
2015-01-20 2015-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.500 2.867 -46,58 97,71 -244.275 280.135
2015-01-20 2015-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -10.900 5.367 -67,01 97,30 -1.060.570 522.209
2015-01-20 2015-01-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 16.267 1.183,90 1,61 24.150 26.190
2014-10-17 2014-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 170.960 -8,07
2014-10-17 2014-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.198 1.208 -49,79 101,20 -121.238 122.250
2014-10-17 2014-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.485 2.406 -75,67 99,80 -747.003 240.119
2014-10-17 2014-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.417 9.891 -35,39 99,05 -536.554 979.704
2014-10-17 2014-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -600 15.308 -3,77 97,74 -58.644 1.496.204
2014-10-17 2014-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -300 15.908 -1,85 96,60 -28.980 1.536.713
2014-10-17 2014-10-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 16.208 1.241,72 1,61 24.150 26.095
2014-10-17 2014-09-09 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
G - Gift 150.000 150.000
2014-10-17 2014-09-09 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
G - Gift -150.000 0 -100,00
2014-10-17 2014-09-09 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
G - Gift 350.000 350.000
2014-10-17 2014-09-09 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
G - Gift -350.000 0 -100,00
2014-07-16 2014-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 155.695 -8,79
2014-07-16 2014-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.000 1.208 -45,29 88,23 -88.230 106.582
2014-07-16 2014-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -6.600 2.208 -74,93 87,05 -574.530 192.206
2014-07-16 2014-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.400 8.808 -45,66 86,28 -638.472 759.954
2014-07-16 2014-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 16.208 1.241,72 1,61 24.150 26.095
2014-06-05 2014-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 150.000 150.000
2014-05-09 2014-05-09 4 PCRX Pacira Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -25.000 170.695 -12,77
2014-05-09 2014-05-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -300 1.208 -19,89 74,80 -22.440 90.358
2014-05-09 2014-05-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -17.300 1.508 -91,98 74,15 -1.282.795 111.818
2014-05-09 2014-05-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.400 18.808 -28,24 73,40 -543.160 1.380.507
2014-05-09 2014-05-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 25.000 26.208 2.069,54 1,61 40.250 42.195
2014-03-13 2014-03-11 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 24.000 24.000
2014-03-13 2014-03-11 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 28.500 28.500
2014-03-13 2014-03-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
J - Other 221 1.208 22,39
2014-02-07 2013-04-16 5 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
G - Gift -2.000 987 -66,96
2014-01-02 2013-12-30 4 PCRX Pacira Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -15.000 195.695 -7,12
2014-01-02 2013-12-30 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.000 2.987 -83,39 55,84 -837.560 166.786
2014-01-02 2013-12-30 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 17.987 502,18 1,61 24.150 28.959
2013-11-20 2013-11-18 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
J - Other 414 2.987 16,09
2013-10-02 2013-09-30 4 PCRX Pacira Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -15.000 210.695 -6,65
2013-10-02 2013-09-30 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.094 2.573 -29,83 47,55 -52.020 122.346
2013-10-02 2013-09-30 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -13.906 3.667 -79,13 47,01 -653.721 172.386
2013-10-02 2013-09-30 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 17.573 582,98 1,61 24.150 28.293
2013-07-11 2013-07-09 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 13.500 13.500
2013-07-11 2013-07-09 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 9.000 9.000
2013-07-02 2013-06-28 4 PCRX Pacira Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -15.000 225.695 -6,23
2013-07-02 2013-06-28 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.000 2.573 -85,36 28,73 -430.966 73.925
2013-07-02 2013-06-28 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 17.573 582,98 1,61 24.150 28.293
2013-04-01 2013-03-28 4 PCRX Pacira Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -15.000 240.695 -5,87
2013-04-01 2013-03-28 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.000 2.573 -85,36 28,66 -429.900 73.742
2013-04-01 2013-03-28 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 17.573 582,98 1,61 24.150 28.293
2013-03-25 2013-03-18 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
J - Other 573 2.573 28,65
2012-12-12 2012-12-10 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 45.000 45.000
2012-06-07 2012-06-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 350.000 350.000
2012-02-10 2011-08-10 5 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
G - Gift -3.000 20.600 -12,71
2011-02-02 3 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
18.600
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)